hydroxychloroquin
offlabel
util
treatment
oral
condit
editor
respons
presid
trump
remark
made
march
concern
potenti
chloroquin
hydroxychloroquin
hcq
treatment
novel
infect
us
food
drug
administr
fda
swiftli
issu
statement
clarifi
drug
approv
treatment
diseas
caus
coronaviru
drug
approv
treat
malaria
lupu
rheumatoid
arthriti
must
still
assess
clinic
trial
declar
safe
effect
treatment
doctor
unit
state
wide
latitud
prescrib
drug
offlabel
mean
condit
beyond
initi
fda
approv
hcq
may
may
pan
success
therapeut
agent
treatment
infect
howev
appear
like
mani
health
care
provid
may
begin
use
drug
without
knowledg
accept
dosag
regimen
toxic
hcq
drug
specif
approv
prevent
treatment
malaria
howev
util
extens
physician
dentist
oral
medicin
clinician
treatment
rheumatolog
condit
system
lupu
erythematosu
sjogren
syndrom
rheumatoid
arthriti
chronic
ulcer
stomat
immun
thrombocytopenia
purpura
lichen
planopilari
oral
lichen
planu
realm
treatment
autoimmun
secretori
oral
mucos
condit
hcq
deem
safe
effect
oral
condit
sjogren
syndrom
chronic
ulcer
stomat
oral
lichen
planu
note
possibl
neg
effect
hcq
druginduc
conjunct
toxic
typic
address
advis
patient
see
ophthalmologist
least
yearli
recent
note
rare
complic
relat
hcq
use
sudden
death
result
particular
cardiac
arrhythmia
torsad
de
point
arrhythmia
associ
prolong
qt
durat
secondari
highdos
hcq
administr
howev
report
olaughlin
et
al
hcqrelat
qt
interv
prolong
secondari
arrhythmia
extrem
rare
may
relat
higher
dosag
regimen
danielsson
et
al
report
result
recent
studi
sudden
death
older
patient
indic
increas
risk
torsad
de
point
arrhythmia
use
select
serotonin
reuptak
inhibitor
citalopram
therefor
appear
possibl
addit
drug
interact
prescrib
hcq
patient
alreadi
take
citalopram
drug
significantli
prolong
qt
durat
increas
risk
torsad
de
point
arrhythmia
year
ago
note
antihistamin
blocker
terfenadin
cardiotox
higher
dose
particular
drug
use
dentistri
ketoconazol
erythromycin
even
grapefruit
juic
could
result
interact
potenti
lethal
serum
valu
possibl
result
cardiotox
specif
torsad
de
point
arrhythmia
death
danger
sudden
death
condit
result
eventu
remov
terfenadin
clinic
therapeut
agent
worldwid
rheumatolog
therapeut
dosag
level
hcq
regard
reason
safe
therapeut
agent
howev
oral
medicin
clinician
health
care
provid
advis
potenti
issu
use
hcq
interact
addit
toxic
qt
durat
prolong
associ
sudden
death
treatment
older
patient
